Stevanato Group (STVN) Prices 32M Share IPO at $21/sh
FREE Breaking News Alerts from StreetInsider.com!
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Stevanato Group Announces Pricing of Initial Public Offering
July 15, 2021 6:41 PM EDTExpects to begin trading on NYSE on July 16, 2021 under ticker symbol STVN
PIOMBINO DESE, Italy--(BUSINESS WIRE)-- Stevanato Group S.p.A. (the Company), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the pricing of its initial public offering of 32,000,000 of its ordinary shares at a price of $21 per share.
The shares are expected to begin trading on the New York Stock Exchange on July 16, 2021, under the ticker symbol STVN. The offering is expected to close on July 20, 2021, subject to customary closing... More
